Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

(68)Ga-Labeling of RGD peptides and biodistribution.

Blom E, Velikyan I, Estrada S, Hall H, Muhammad T, Ding C, Nair M, Långström B.

Int J Clin Exp Med. 2012;5(2):165-72. Epub 2012 Apr 6.

2.

Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.

Jeong JM, Hong MK, Chang YS, Lee YS, Kim YJ, Cheon GJ, Lee DS, Chung JK, Lee MC.

J Nucl Med. 2008 May;49(5):830-6. doi: 10.2967/jnumed.107.047423. Epub 2008 Apr 15.

3.

The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26.

Varasteh Z, Mitran B, Rosenström U, Velikyan I, Rosestedt M, Lindeberg G, Sörensen J, Larhed M, Tolmachev V, Orlova A.

Nucl Med Biol. 2015 May;42(5):446-54. doi: 10.1016/j.nucmedbio.2014.12.009. Epub 2014 Dec 20.

PMID:
25684649
4.

Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.

Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS.

J Nucl Med. 2004 Oct;45(10):1776-83.

5.

Influence of macrocyclic chelators on the targeting properties of (68)Ga-labeled synthetic affibody molecules: comparison with (111)In-labeled counterparts.

Strand J, Honarvar H, Perols A, Orlova A, Selvaraju RK, Karlström AE, Tolmachev V.

PLoS One. 2013 Aug 1;8(8):e70028. doi: 10.1371/journal.pone.0070028. Print 2013.

6.

Dual receptor-targeting ⁹⁹mTc-labeled Arg-Gly-Asp-conjugated Alpha-Melanocyte stimulating hormone hybrid peptides for human melanoma imaging.

Xu J, Yang J, Miao Y.

Nucl Med Biol. 2015 Apr;42(4):369-74. doi: 10.1016/j.nucmedbio.2014.11.002. Epub 2014 Nov 13.

7.

68Ga-labeling of biotin analogues and their characterization.

Blom E, Långström B, Velikyan I.

Bioconjug Chem. 2009 Jun;20(6):1146-51. doi: 10.1021/bc800538s.

PMID:
19453100
8.

PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In.

Roosenburg S, Laverman P, Joosten L, Cooper MS, Kolenc-Peitl PK, Foster JM, Hudson C, Leyton J, Burnet J, Oyen WJ, Blower PJ, Mather SJ, Boerman OC, Sosabowski JK.

Mol Pharm. 2014 Nov 3;11(11):3930-7. doi: 10.1021/mp500283k. Epub 2014 Jul 11.

PMID:
24992368
9.

A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.

Pan D, Xu YP, Yang RH, Wang L, Chen F, Luo S, Yang M, Yan Y.

Amino Acids. 2014 Jun;46(6):1481-9. doi: 10.1007/s00726-014-1718-y. Epub 2014 Mar 17.

PMID:
24633452
10.

N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging.

Gourni E, Mansi R, Jamous M, Waser B, Smerling C, Burian A, Buchegger F, Reubi JC, Maecke HR.

J Nucl Med. 2014 Oct;55(10):1719-25. doi: 10.2967/jnumed.114.141242. Epub 2014 Aug 21.

11.

Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling.

Tsionou MI, Knapp CE, Foley CA, Munteanu CR, Cakebread A, Imberti C, Eykyn TR, Young JD, Paterson BM, Blower PJ, Ma MT.

RSC Adv. 2017 Oct 24;7(78):49586-49599. doi: 10.1039/c7ra09076e. Epub 2017 Oct 25.

12.

Synthesis of (68)Ga-labeled NOTA-RGD-GE11 heterodimeric peptide for dual integrin and epidermal growth factor receptor-targeted tumor imaging.

Yu HM, Chen JH, Lin KL, Lin WJ.

J Labelled Comp Radiopharm. 2015 Jun 15;58(7):299-303. doi: 10.1002/jlcr.3296. Epub 2015 May 21.

PMID:
25997858
13.

One-step radiosynthesis of ¹⁸F-AlF-NOTA-RGD₂ for tumor angiogenesis PET imaging.

Liu S, Liu H, Jiang H, Xu Y, Zhang H, Cheng Z.

Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1732-41. doi: 10.1007/s00259-011-1847-4. Epub 2011 May 27.

14.
15.

(18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.

Liu Z, Yan Y, Liu S, Wang F, Chen X.

Bioconjug Chem. 2009 May 20;20(5):1016-25. doi: 10.1021/bc9000245.

16.

Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers.

Shi J, Kim YS, Chakraborty S, Zhou Y, Wang F, Liu S.

Amino Acids. 2011 Nov;41(5):1059-70. doi: 10.1007/s00726-009-0439-0. Epub 2010 Jan 6.

PMID:
20052508
17.

Gallium-67-labeled lactam bridge-cyclized alpha-MSH peptides with enhanced melanoma uptake and reduced renal uptake.

Guo H, Gallazzi F, Miao Y.

Bioconjug Chem. 2012 Jun 20;23(6):1341-8. doi: 10.1021/bc300191z. Epub 2012 Jun 5.

18.

Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers.

Shi J, Kim YS, Zhai S, Liu Z, Chen X, Liu S.

Bioconjug Chem. 2009 Apr;20(4):750-9. doi: 10.1021/bc800455p.

19.

Tailored Gallium(III) chelator NOPO: synthesis, characterization, bioconjugation, and application in preclinical Ga-68-PET imaging.

Simeček J, Zemek O, Hermann P, Notni J, Wester HJ.

Mol Pharm. 2014 Nov 3;11(11):3893-903. doi: 10.1021/mp400642s. Epub 2013 Dec 18.

PMID:
24350645
20.

Convenient preparation of 68Ga-based PET-radiopharmaceuticals at room temperature.

Velikyan I, Maecke H, Langstrom B.

Bioconjug Chem. 2008 Feb;19(2):569-73. doi: 10.1021/bc700341x. Epub 2008 Jan 19.

PMID:
18205327

Supplemental Content

Support Center